- Home
- NLSP vs EGHT Comparison
NLSP vs EGHT Comparison
Compare NLSP & EGHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NLSP
- EGHT
- Stock Information
- Founded
- NLSP 2015
- EGHT 1987
- Country
- NLSP Switzerland
- EGHT United States
- Employees
- NLSP N/A
- EGHT N/A
- Industry
- NLSP Biotechnology: Pharmaceutical Preparations
- EGHT EDP Services
- Sector
- NLSP Health Care
- EGHT Technology
- Exchange
- NLSP Nasdaq
- EGHT Nasdaq
- Market Cap
- NLSP 243.8M
- EGHT 250.2M
- IPO Year
- NLSP 2021
- EGHT 1997
- Fundamental
- Price
- NLSP $4.45
- EGHT $1.96
- Analyst Decision
- NLSP
- EGHT Buy
- Analyst Count
- NLSP 0
- EGHT 6
- Target Price
- NLSP N/A
- EGHT $2.83
- AVG Volume (30 Days)
- NLSP 32.3K
- EGHT 842.1K
- Earning Date
- NLSP 10-18-2024
- EGHT 10-30-2024
- Dividend Yield
- NLSP N/A
- EGHT N/A
- EPS Growth
- NLSP N/A
- EGHT N/A
- EPS
- NLSP N/A
- EGHT N/A
- Revenue
- NLSP N/A
- EGHT $723,565,000.00
- Revenue This Year
- NLSP N/A
- EGHT $0.85
- Revenue Next Year
- NLSP N/A
- EGHT $2.15
- P/E Ratio
- NLSP N/A
- EGHT N/A
- Revenue Growth
- NLSP N/A
- EGHT N/A
- 52 Week Low
- NLSP $4.08
- EGHT $1.51
- 52 Week High
- NLSP $35.60
- EGHT $3.92
- Technical
- Relative Strength Index (RSI)
- NLSP 36.17
- EGHT 50.53
- Support Level
- NLSP $4.72
- EGHT $1.78
- Resistance Level
- NLSP $5.36
- EGHT $2.20
- Average True Range (ATR)
- NLSP 0.56
- EGHT 0.11
- MACD
- NLSP -0.01
- EGHT -0.00
- Stochastic Oscillator
- NLSP 19.79
- EGHT 42.86
About NLSP NLS Pharmaceutics Ltd.
NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.
About EGHT 8x8 Inc
8x8 Inc provides contact-center-as-a-service and unified-communications-as-a-service software applications to approximately 2.5 million users. The company's unified platform enables omnichannel communication to assist employees in communicating across voice, video, text, chat, and contact centers. The Company also generates revenue from sales of hardware and professional services, which are complementary to the delivery of its integrated technology platform.. Geographically, it derives a majority of revenue from the United States.